Amplifon S.p.A EBITDA 2019-2024 | AMFPF
Amplifon S.p.A annual and quarterly EBITDA history from 2019 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Amplifon S.p.A EBITDA for the quarter ending September 30, 2024 was $0.147B, a 105.91% increase year-over-year.
- Amplifon S.p.A EBITDA for the twelve months ending September 30, 2024 was $0.508B, a 47.5% decline year-over-year.
- Amplifon S.p.A 2024 annual EBITDA was $0.607B, a 6.48% increase from 2023.
- Amplifon S.p.A 2023 annual EBITDA was $0.57B, a 4.34% increase from 2022.
- Amplifon S.p.A 2022 annual EBITDA was $0.547B, a 1.39% decline from 2021.
| Amplifon S.p.A Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $607 |
| 2023 | $570 |
| 2022 | $547 |
| 2021 | $554 |
| 2020 | $424 |
| 2019 | $415 |
| 2018 | $266 |
| Amplifon S.p.A Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $147 |
| 2023-03-31 | $124 |
| 2022-03-31 | $123 |
| 2021-03-31 | $114 |
| 2020-03-31 | $72 |
| 2019-03-31 | $88 |
| 2018-12-31 | $456 |
| 2018-09-30 | $353 |
| 2018-06-30 | $430 |
| 2018-03-31 | $380 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.378B | $2.607B |
| Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.024B | 25.89 |
| CVS Health (CVS) | United States | $80.885B | 10.05 |
| Elevance Health (ELV) | United States | $75.961B | 9.80 |
| Cencora (COR) | United States | $57.110B | 19.87 |
| DiDi Global (DIDIY) | China | $25.792B | 27.40 |
| Labcorp Holdings (LH) | United States | $20.561B | 16.68 |
| Natera (NTRA) | United States | $20.462B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.598B | 0.00 |
| CochLear (CHEOY) | Australia | $12.760B | 0.00 |
| Solventum (SOLV) | United States | $12.748B | 13.49 |
| ICON (ICLR) | Ireland | $11.757B | 10.93 |
| Revvity (RVTY) | United States | $11.304B | 19.45 |
| Viatris (VTRS) | United States | $10.481B | 3.60 |
| Medpace Holdings (MEDP) | United States | $8.988B | 23.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.788B | 0.00 |
| Avantor (AVTR) | United States | $8.736B | 12.69 |
| HealthEquity (HQY) | United States | $8.317B | 36.43 |
| Charles River Laboratories (CRL) | United States | $7.584B | 14.86 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $4.851B | 28.56 |
| BrightSpring Health Services (BTSG) | United States | $3.527B | 32.35 |
| Sotera Health (SHC) | United States | $3.230B | 18.35 |
| Surgery Partners (SGRY) | United States | $2.799B | 36.40 |
| Alignment Healthcare (ALHC) | United States | $2.623B | 0.00 |
| Concentras Parent (CON) | United States | $2.543B | 14.70 |
| Organon (OGN) | United States | $2.485B | 2.64 |
| GeneDx Holdings (WGS) | United States | $2.331B | 89.77 |
| Progyny (PGNY) | United States | $1.992B | 43.85 |
| Ardent Health (ARDT) | United States | $1.991B | 8.49 |
| PACS (PACS) | United States | $1.897B | 0.00 |
| Premier (PINC) | United States | $1.719B | 13.05 |
| GoodRx Holdings (GDRX) | United States | $1.697B | 33.93 |
| Teladoc Health (TDOC) | United States | $1.388B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.285B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.100B | 8.37 |
| CareDx (CDNA) | United States | $1.058B | 16.53 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.911B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.761B | 7.13 |
| Nutex Health (NUTX) | United States | $0.632B | 9.57 |
| InnovAge Holding (INNV) | United States | $0.564B | 0.00 |
| Embecta (EMBC) | United States | $0.560B | 3.77 |
| SBC Medicals (SBC) | United States | $0.511B | 0.00 |
| LifeMD (LFMD) | United States | $0.497B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.473B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.472B | 10.63 |
| Omada Health (OMDA) | $0.463B | 0.00 | |
| So-Young (SY) | China | $0.455B | 0.00 |
| Enhabit (EHAB) | United States | $0.354B | 29.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.333B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.265B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 23.17 |
| Pheton Holdings (PTHL) | China | $0.136B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.072B | 0.00 |
| KindlyMD (NAKA) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |